{"transactions":[{"id":4626616,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-25T01:49:40.000Z","date":"2026-09-22","kind":"sale","planned":false,"acquired":false,"shares":104320,"price":28.8085,"value":3005302.72,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold by Catalys Pacific Fund, LP. See footnote (3)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $28.700 to $28.905. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares of common stock held of record by Catalys Pacific Fund, LP. Catalys Pacific Fund GP, LP is the general partner of Catalys Pacific Fund, LP. Catalys Pacific, LLC is the general partner of Catalys Pacific Fund GP, LP, and Mr. Slingsby is the managing partner of Catalys Pacific, LLC. Accordingly,  Mr. Slingsby may be deemed to share voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Mr. Slingsby disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":7805718,"source":{"system":"sec-edgar","filing":"0001963901-26-000003","document":"wk-form4_1790300978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1963901/000196390126000003/wk-form4_1790300978.xml","form_type":"4"}},{"id":890053,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2026-02-21T00:47:18.000Z","date":"2026-02-19","kind":"other","planned":false,"acquired":true,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents stock options or RSUs transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in 12 substantially equal monthly installments following the date of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, the general partner of the General Partner. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":8300,"derivative":{"exercise_price":28.06,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001933414-26-000041","document":"wk-form4_1771634836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1933414/000193341426000041/wk-form4_1771634836.xml","form_type":"4"}},{"id":890052,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2026-02-21T00:47:18.000Z","date":"2026-02-19","kind":"other","planned":false,"acquired":false,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents stock options or RSUs transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in 12 substantially equal monthly installments following the date of grant."}],"balance_after":0,"derivative":{"exercise_price":28.06,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001933414-26-000041","document":"wk-form4_1771634836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1933414/000193341426000041/wk-form4_1771634836.xml","form_type":"4"}},{"id":890051,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2026-02-21T00:47:18.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":8300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in 12 substantially equal monthly installments following the date of grant."}],"balance_after":8300,"derivative":{"exercise_price":28.06,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":8300},"source":{"system":"sec-edgar","filing":"0001933414-26-000041","document":"wk-form4_1771634836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1933414/000193341426000041/wk-form4_1771634836.xml","form_type":"4"}},{"id":890050,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-21T00:47:18.000Z","date":"2026-02-19","kind":"other","planned":false,"acquired":true,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents stock options or RSUs transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP."},{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting of these RSUs in one annual installment following the date of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, the general partner of the General Partner. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":7910038,"source":{"system":"sec-edgar","filing":"0001933414-26-000041","document":"wk-form4_1771634836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1933414/000193341426000041/wk-form4_1771634836.xml","form_type":"4"}},{"id":890049,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-21T00:47:18.000Z","date":"2026-02-19","kind":"other","planned":false,"acquired":false,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents stock options or RSUs transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP."},{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting of these RSUs in one annual installment following the date of grant."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001933414-26-000041","document":"wk-form4_1771634836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1933414/000193341426000041/wk-form4_1771634836.xml","form_type":"4"}},{"id":890048,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-21T00:47:18.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting of these RSUs in one annual installment following the date of grant."}],"balance_after":6200,"source":{"system":"sec-edgar","filing":"0001933414-26-000041","document":"wk-form4_1771634836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1933414/000193341426000041/wk-form4_1771634836.xml","form_type":"4"}},{"id":990982,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-21T18:07:59.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":1000000,"price":43.35,"value":43350000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":7903838,"source":{"system":"sec-edgar","filing":"0001933414-25-000156","document":"wk-form4_1763766476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000193341425000156/wk-form4_1763766476.xml","form_type":"4"}},{"id":1165428,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-04-25T19:01:59.000Z","date":"2025-03-13","kind":"purchase","planned":false,"acquired":true,"shares":259259,"price":13.5,"value":3499996.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":8903838,"source":{"system":"sec-edgar","filing":"0001933414-25-000052","document":"wk-form4_1745622111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000193341425000052/wk-form4_1745622111.xml","form_type":"4"}},{"id":1248810,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2025-02-24T18:59:23.000Z","date":"2025-02-13","kind":"other","planned":false,"acquired":true,"shares":32900,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents stock options transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 12 substantially equal monthly installments following the date of grant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":32900,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":32900},"source":{"system":"sec-edgar","filing":"0001933414-25-000017","document":"wk-form4_1740441556.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000193341425000017/wk-form4_1740441556.xml","form_type":"4"}},{"id":1248809,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2025-02-24T18:59:23.000Z","date":"2025-02-13","kind":"other","planned":false,"acquired":false,"shares":32900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents stock options transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 12 substantially equal monthly installments following the date of grant."}],"balance_after":0,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":32900},"source":{"system":"sec-edgar","filing":"0001933414-25-000017","document":"wk-form4_1740441556.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000193341425000017/wk-form4_1740441556.xml","form_type":"4"}},{"id":1248808,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2025-02-24T18:59:23.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":32900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 12 substantially equal monthly installments following the date of grant."}],"balance_after":32900,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":32900},"source":{"system":"sec-edgar","filing":"0001933414-25-000017","document":"wk-form4_1740441556.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000193341425000017/wk-form4_1740441556.xml","form_type":"4"}},{"id":1307458,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2025-01-07T17:58:54.000Z","date":"2024-05-22","kind":"other","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents stock options transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in 12 substantially equal monthly installments beginning on June 22, 2024. In the event that the next annual meeting of stockholders occurs prior to May 22, 2025, any remaining unvested portion of the stock option award will vest on the date of such meeting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":22000,"derivative":{"exercise_price":12.52,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001933414-25-000001","document":"wk-form4_1736290727.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000193341425000001/wk-form4_1736290727.xml","form_type":"4"}},{"id":1307457,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2025-01-07T17:58:54.000Z","date":"2024-05-22","kind":"other","planned":false,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents stock options transferred pursuant to an option transfer agreement between the Reporting Person and Catalys Pacific Fund, LP."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option award vests in 12 substantially equal monthly installments beginning on June 22, 2024. In the event that the next annual meeting of stockholders occurs prior to May 22, 2025, any remaining unvested portion of the stock option award will vest on the date of such meeting."}],"balance_after":0,"derivative":{"exercise_price":12.52,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001933414-25-000001","document":"wk-form4_1736290727.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000193341425000001/wk-form4_1736290727.xml","form_type":"4"}},{"id":1447880,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-26T21:45:51.000Z","date":"2024-07-24","kind":"sale","planned":false,"acquired":false,"shares":550000,"price":13.05,"value":7177500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, the general partner of the General Partner. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":8644579,"source":{"system":"sec-edgar","filing":"0001628280-24-033205","document":"wk-form4_1722044745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000162828024033205/wk-form4_1722044745.xml","form_type":"4"}},{"id":1503178,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2024-05-23T16:21:15.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests in 12 substantially equal monthly installments beginning on June 22, 2024. In the event that the next annual meeting of stockholders occurs prior to May 22, 2025, any remaining unvested portion of the stock option award will vest on the date of such meeting."}],"balance_after":22000,"derivative":{"exercise_price":12.52,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001933414-24-000019","document":"wk-form4_1716495657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000193341424000019/wk-form4_1716495657.xml","form_type":"4"}},{"id":1829374,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2023-07-14T08:55:15.000Z","date":"2023-07-12","kind":"other","planned":false,"acquired":true,"shares":88000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents stock options transferred pursuant to option transfer agreements between Catalys Pacific Fund, LP and each of Brian Taylor Slingsby and Takeshi Takahashi."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 36 monthly installments beginning on March 9, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, which is the general partner of Catalys Pacific Fund GP, LP. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":88000,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":88000},"source":{"system":"sec-edgar","filing":"0001933414-23-000043","document":"wf-form4_168933930313513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000193341423000043/wf-form4_168933930313513.xml","form_type":"4"}},{"id":1829373,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2023-07-14T08:55:15.000Z","date":"2023-07-12","kind":"other","planned":false,"acquired":false,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents stock options transferred pursuant to an option transfer agreement between Brian Taylor Slingsby and Catalys Pacific Fund, LP."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 36 monthly installments beginning on March 9, 2023."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001933414-23-000043","document":"wf-form4_168933930313513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000193341423000043/wf-form4_168933930313513.xml","form_type":"4"}},{"id":2010420,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2023-02-16T16:54:03.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":2142751,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, the general partner of the General Partner. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2142751},"source":{"system":"sec-edgar","filing":"0001628280-23-003922","document":"wf-form4_167658442850041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000162828023003922/wf-form4_167658442850041.xml","form_type":"4"}},{"id":2010419,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-02-16T16:54:03.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":2171342,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, the general partner of the General Partner. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2171342},"source":{"system":"sec-edgar","filing":"0001628280-23-003922","document":"wf-form4_167658442850041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000162828023003922/wf-form4_167658442850041.xml","form_type":"4"}},{"id":2010418,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-16T16:54:03.000Z","date":"2023-02-14","kind":"purchase","acquired":true,"shares":250000,"price":16,"value":4000000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, the general partner of the General Partner. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":9194579,"source":{"system":"sec-edgar","filing":"0001628280-23-003922","document":"wf-form4_167658442850041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000162828023003922/wf-form4_167658442850041.xml","form_type":"4"}},{"id":2010417,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-16T16:54:03.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":4314093,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock of the Issuer automatically converted into shares of common stock on a 10.798-for-one basis (which reflects the reverse stock split effected by the Issuer on February 1, 2023) upon closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by Catalys Pacific Fund, LP. The general partner of Catalys Pacific Fund, LP is Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing partner of Catalys Pacific, LLC, the general partner of the General Partner. Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby may be deemed to have voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Each of Catalys Pacific, LLC, Catalys Pacific Fund GP, LP and Brian Taylor Slingsby disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":8944579,"source":{"system":"sec-edgar","filing":"0001628280-23-003922","document":"wf-form4_167658442850041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000162828023003922/wf-form4_167658442850041.xml","form_type":"4"}},{"id":2019326,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65359,"kind":"person","name":"Slingsby Brian Taylor","position":1,"cik":"0001963901","reported_name":"Slingsby Brian Taylor","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72712,"kind":"organization","name":"Catalys Pacific Fund, LP","position":2,"cik":"0001746274","reported_name":"Catalys Pacific Fund, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2023-02-13T21:03:52.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 36 monthly installments beginning on March 9, 2023."}],"balance_after":44000,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001628280-23-003431","document":"wf-form4_167634020870900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746274/000162828023003431/wf-form4_167634020870900.xml","form_type":"4"}}]}